Addressing Hypertension Care in Africa Program
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hyperten
| Condition(s) | Hypertension, High Blood Pressure |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease. |
| Who can participate | Inclusion Criteria: * Aged 18 -70 years. * Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis. * Hypertension treatment naive or on monotherapy. * Receives primary care at one of the participating sites. * Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba. * Owns a smartphone (Android or iOS). Exclusion Criteria: * Age \<18 years or \>70 years. * Severely elevated BP (≥180/110mmHg). * Diagnosis of stroke, coronary artery disease, or kidney disease. * Diagnosis of end-stage renal disease (ESRD) treated with dialysis. * Serious medical condition which either limits life expectancy or requires active management (e.g., cancer). * Cognitive impairment or other |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Lead sponsor | Johns Hopkins University |
| Locations | Baltimore, Maryland, United States; Bekwai, Ashanti Region, Ghana; Kumasi, Ashanti Region, Ghana; Kumasi, Ashanti Region, Ghana; Tafo, Ashanti Region, Ghana; Berekum, Bono, Ghana (+11 more sites) |
| Start date | 2026-01-09 |
| NCT ID | NCT06986590 |
| Official listing | https://clinicaltrials.gov/study/NCT06986590 |